BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 9626040)

  • 1. Long-term survival in Waldenström's macroglobulinemia.
    Frase LL; Stone MJ; Sammons CA
    Am J Med; 1998 May; 104(5):507-8. PubMed ID: 9626040
    [No Abstract]   [Full Text] [Related]  

  • 2. Hyperviscosity syndrome in Waldenström's macroglobulinemia.
    Krol TC; Wood WS
    Am Fam Physician; 1981 Aug; 24(2):187-9. PubMed ID: 6789661
    [No Abstract]   [Full Text] [Related]  

  • 3. Waldenström's macroglobulinemia: prognostic factors and recent therapeutic advances.
    Leblond V; Tournilhac O; Morel P
    Clin Exp Med; 2004 Apr; 3(4):187-98. PubMed ID: 15103509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of Waldenstrom's macroglobulinemia].
    Liaudet J; Ernoult JL
    Presse Med (1893); 1970 May; 78(22):1021. PubMed ID: 4986543
    [No Abstract]   [Full Text] [Related]  

  • 5. [Bilateral occlusion of the central vein of the retina disclosing Waldenström's disease].
    Nabet L; Dufier JL; Cornu P; Junghers P; Chauvin JC; de Monteynard MS; Manderieux N; Haye C
    Bull Soc Ophtalmol Fr; 1989 Jan; 89(1):39-41. PubMed ID: 2513133
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment recommendations in Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia.
    Gertz MA; Anagnostopoulos A; Anderson K; Branagan AR; Coleman M; Frankel SR; Giralt S; Levine T; Munshi N; Pestronk A; Rajkumar V; Treon SP
    Semin Oncol; 2003 Apr; 30(2):121-6. PubMed ID: 12720120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Waldenström's disease with pulmonary involvement].
    Baldus M; Stark M; Klooker P; Schleiffer T; Brass H
    Med Klin (Munich); 1992 Aug; 87(8):437-40. PubMed ID: 1406478
    [No Abstract]   [Full Text] [Related]  

  • 8. [Waldenström's macroglobulinemia: clinical aspects, diagnosis and therapy].
    Baldus M; Brass H
    Med Klin (Munich); 1992 Aug; 87(8):434-6. PubMed ID: 1406477
    [No Abstract]   [Full Text] [Related]  

  • 9. Plasma exchange in the long-term management of Waldenström's macroglobulinemia.
    Buskard NA; Galton DA; Goldman JM; Kohner EM; Grindle CF; Newman DL; Twinn KW; Lowenthal RM
    Can Med Assoc J; 1977 Jul; 117(2):135-7. PubMed ID: 406031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allogeneic bone marrow transplantation for advanced Waldenstrom's macroglobulinemia.
    Martino R; Shah A; Romero P; Brunet S; Sierra J; Domingo-Albós A; Fruchtman S; Isola L
    Bone Marrow Transplant; 1999 Apr; 23(7):747-9. PubMed ID: 10218857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advanced Waldenström's macroglobulinemia: usefulness of Morel's scoring system in establishing prognosis.
    Lévy V; Morel P; Porcher R; Chevret S; Wattel E; Leblond V
    Haematologica; 2005 Feb; 90(2):279-81. PubMed ID: 15710594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Case report: bilateral simultaneous central retinal vein occlusion in Waldenström's macroglobulinemia.
    Chanana B; Gupta N; Azad RV
    Optometry; 2009 Jul; 80(7):350-3. PubMed ID: 19545847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Myeloma and Waldenström's macroglobulinemia].
    Palva I
    Duodecim; 1989; 105(11):1088-94. PubMed ID: 2502371
    [No Abstract]   [Full Text] [Related]  

  • 14. Serum-free light chain elevation is associated with a shorter time to treatment in Waldenstrom's macroglobulinemia.
    Itzykson R; Le Garff-Tavernier M; Katsahian S; Diemert MC; Musset L; Leblond V
    Haematologica; 2008 May; 93(5):793-4. PubMed ID: 18450739
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical and rheological studies in a patient with hyperviscosity syndrome due to Waldenström's macroglobulinemia.
    Somer T; Ditzel J
    Bibl Haematol; 1981; (47):242-6. PubMed ID: 6802129
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of intensive plasmapheresis on the "syndrome of increased viscosity" and blood coagulation system in Waldenstrom's macroglobulinemia].
    Mokeeva RA; Zhuravlev VS
    Probl Gematol Pereliv Krovi; 1969 Mar; 14(3):8-16. PubMed ID: 4981700
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment of Waldenstrom's macroglobulinemia].
    Mokeeva RA
    Sov Med; 1976 Aug; (8):33-8. PubMed ID: 827026
    [No Abstract]   [Full Text] [Related]  

  • 18. High-dose chemotherapy followed by stem cell transplantation in patients with resistant Waldenstrom's macroglobulinemia.
    Anagnostopoulos A; Dimopoulos MA; Aleman A; Weber D; Alexanian R; Champlin R; Giralt S
    Bone Marrow Transplant; 2001 May; 27(10):1027-9. PubMed ID: 11438816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Therapeutic effects of plasmapheresis in Waldenström's disease].
    Moulinier J; Servantie X; Mesnier F
    J Med Bord; 1967 Sep; 144(9):1295-300. PubMed ID: 4988704
    [No Abstract]   [Full Text] [Related]  

  • 20. [Secondary biochemical syndrome and IgM hypermacroglobulinemia in Waldenström's disease].
    Mebazaa A; Ollier MP; Degrelle H; Lazar P; Filitti-Wurmser S; Hartmann L
    Ann Biol Clin (Paris); 1970; 28(1):25-40. PubMed ID: 4986988
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.